Ethylene oxide (EO) sterilization is the most complicated of the industrial sterilization methods. It is not uncommon for anomalies to occur during qualification or routine processing. These anomalies may come in the form of sterilization cycle parameter that is not achieved or a positive biological indicator. Not knowing how to respond to these situations can result in a response that results in the release of product that might not meet the required sterility assurance level (SAL) or the needless resterilization of product. Regulatory action can result from the prior while additional expense to the company can result from the latter. Neither of these situations is of benefit to a manufacturer.
This webinar will outline the various parameters and what actions should be taken when they are not compliant to the process specification. These actions may be as simple as a rationale for release to as complicated as the need for the qualification of a new sterilization process. How to decide the course to take will be addressed along with the reasons behind the decisions so that an accurate and complete justification of your decision can be made for both management and regulatory agencies. The rationales for both conventional and parametric release will be addressed.
Areas Covered in the Webinar:
· What is a cycle anomaly?
· What cycle specifications are critical for sterilization?
· What cycle specifications are critical for product residuals?
· Actions to be taken for critical deviations/anomalies
· Actions to be taken for non-critical deviations/anomalies
· What testing can be performed to justify product release?
· Developing a specification to address actions
· How to document your rationale
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Gerry O'Dell, is owner and President of Gerry O'Dell Consulting, a consulting firm based in the United States with medical device and pharmaceutical clients around the world. Prior to starting Gerry O'Dell Consulting, she worked for Johnson & Johnson Medical, Inc. as the Manager of Laboratory & Sterilization Services which managed the sterilization program for J&J Medical in addition to providing laboratory testing services to several J&J companies. Before becoming a part of Johnson & Johnson Medical, Gerry was Manager of Sterilization Services at Critikon, Inc where she started as a Lab Technician. She holds both a Bachelor and Master of Science degree in Microbiology from the University of South Florida and has over twenty-nine years of experience in the medical device industry.